New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
MEDXvsETF 2ETF Comparison
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with MEDX, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
MEDX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MEDX ETF 2 | -2.94%– | +1.44%– | +0.53%– | +19.98%– | +26.64%– | n/a– |
| Flows | MEDX ETF 2 | -– | -– | -– | -$787K– | -$2M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MEDX ETF 2 | +18.72%– | +20.53%– | +16.49%– | n/a– |
| Max drawdown | MEDX ETF 2 | -5.79%– | -15.58%– | -23.05%– | n/a– |
| Max drawdown duration | MEDX ETF 2 | 11d– | 148d– | 393d– | n/a– |
Trading data
MEDX | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $33.42 | – |
| Previous close 03/12/2026 | $33.89 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
MEDX | ETF 2 | |
|---|---|---|
| Last price | $33.42 | – |
| 1D performance | -1.38% | – |
| AuM | $19.05 M | – |
| E/R | 0.85% | – |
Characteristics
MEDX | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Horizon Kinetics LLC | – |
| Benchmark | - | – |
| N° of holdings | 24 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 27, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
MEDX
USA
84.84%
Other
15.16%
ETF 2
Sectors
MEDX
Health Care
74.67%
Other
25.33%
ETF 2
Advertisement
Diversification
MEDX
Total weight of top 15 holdings out of 15
81.25%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
MEDX
LILLY
17.29%
ABBVIE
8.44%
US66987V1098
7.14%
JOHNSON&JOHNSON
5.50%
US0463531089
5.38%
IONIS PHARMACEUTICALS INC
5.14%
BRISTOL-MYERS SQUIBB
4.60%
ALNYLAM PHARMACEUTICALS
4.36%
AMGEN-T
4.06%
ALKERMES
3.93%
MERCK & CO INC
3.61%
PFIZER
3.37%
CRISPR THERAPEUTICS
2.85%
US37733W2044
2.84%
BIOGEN INC
2.74%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
